How do Driver Mutations Influence Cancer Therapies?
Driver mutations are key targets for cancer therapies. Drugs like imatinib and vemurafenib specifically inhibit the activity of proteins encoded by mutated driver genes. Personalized medicine approaches aim to tailor treatments based on the specific driver mutations present in a patient's tumor.
